EDNSF:OTC-Eden Research plc (USD)

COMMON STOCK | Agricultural Inputs |

Last Closing

USD 0.035

Change

0.00 (0.00)%

Market Cap

USD 0.02B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Eden Research plc, together with its subsidiaries, develops and sells biopesticides solution for crop protection, animal health, and consumer products industries in the United Kingdom and Europe. The company provides crop protection products for foliar disease and insect control, open field and greenhouses, soil pests, post-harvest shelf-life extension, and seed treatment applications under the Mevalone and Cedroz brand names. It also offers animal health products, such as companion animal, bio-control, parasite treatments, and insect spray products. In addition, the company provides consumer products comprising head-lice treatment products, deodorants, odor neutralizers, fragrances, wound care products, food flavorings, and active ingredient supply/delivery products. Eden Research plc was incorporated in 1995 and is headquartered in Abingdon, the United Kingdom.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-06-05 )

Largest Industry Peers for Agricultural Inputs

Symbol Name Price(Change) Market Cap
YRAIF Yara International ASA

N/A

USD 8.31B
KPLUF K&S AG

N/A

USD 3.14B
KNKZF KWS SAAT SE & Co. KGaA

N/A

USD 2.13B
BWEL Boswell J G Co

+5.00 (+0.92%)

USD 0.50B
MBCF Itafos Inc

-0.05 (-2.82%)

USD 0.32B
VRDR Verde Resources Inc

N/A

USD 0.12B
CHYI Chykingyoung Investment Develo..

N/A

USD 0.11B
MGROF Mustgrow Biologics Corp

-0.01 (-1.89%)

USD 0.03B
PUBC PureBase Corp

N/A

USD 0.02B
VNPKF Verde Agritech Ltd.

-0.07 (-19.64%)

USD 0.02B

ETFs Containing EDNSF

N/A

Market Performance

  Market Performance vs. Industry/Classification (Agricultural Inputs) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -30.00% 40% F 18% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -30.00% 38% F 17% F
Trailing 12 Months  
Capital Gain -35.19% 52% F 28% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -35.19% 52% F 27% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -7.98% 38% F 29% F
Dividend Return -7.98% 35% F 27% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 13.73% 100% F 93% A
Risk Adjusted Return -58.12% 12% F 14% F
Market Capitalization 0.02B 61% D- 45% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector